Xenon Pharmaceuticals Inc (XENE)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -34.993 | -54.053 | -40.934 | -30.797 | -16.631 | -20.254 | -18.842 | -21.222 |
Return on Equity (%) | -36.814 | -61.509 | -49.554 | -42.602 | -21.276 | -21.372 | -19.651 | -22.116 |
Return on Invested Capital (%) | -40.211 | -61.87 | -47.485 | -38.905 | -23.055 | -22.281 | -23.172 | -35.869 |
Operating Margin (%) | -1275.485 | -9872.669 | N/A | -588.432 | -88.945 | -427.879 | -1327.698 | N/A |
Net Profit Margin (%) | -1275.485 | -9872.669 | N/A | -609.094 | -87.089 | -418.11 | -1324.316 | N/A |
Book Value Per Share | 3.564 | 1.997 | 3.711 | 2.89 | 4.542 | 10.3 | 11.528 | 12.312 |
Earnings Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.778 | -1.464 | -1.996 | -2.42 |
Cash Per Share | 0.953 | 1.138 | 2.631 | 0.849 | 1.249 | 3.337 | 0.915 | 1.972 |
Working Capital Per Share | 3.467 | 2.263 | 4.556 | 3.481 | 4.635 | 10.345 | 9.229 | 8.195 |
Operating Profit Per Share | 0.101 | 0.017 | N/A | 0.234 | 0.893 | 0.35 | 0.151 | N/A |
EBIT Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.808 | -1.498 | -2.001 | -2.424 |
EBITDA Per Share | -1.283 | -1.706 | -1.34 | -1.427 | -0.808 | -1.498 | -2.001 | -2.424 |
Free Cash Flow Per Share | -1.315 | -1.725 | -1.343 | -1.399 | -0.704 | -1.425 | -1.976 | -2.392 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 18.679 | 10.977 | 29.482 | 3.34 | 12.298 | 39.032 | 26.443 | 23.648 |
Quick Ratio | 18.301 | 10.802 | 29.027 | 3.277 | 12.098 | 38.719 | 26.124 | 23.428 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 17.93M | 18M | 25.75M | 28.14M | 35.01M | 51.64M | 62.59M | 75.37M |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | 62.24M | 62.54M | 62.59M | 63.11M | 63.72M | 65M | 75.37M | 75.46M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 23.714 | N/A | N/A | N/A | 31.823 |
Quick Ratio | N/A | N/A | N/A | 23.532 | N/A | N/A | N/A | 31.518 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.24B |
Price to Earnings Ratio | -17.76 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 21.79 |
Price to Book Ratio | 3.49 |
Dividend Yield | - |
Shares Outstanding | 75.47M |
Average Volume (1 week) | 533.34k |
Average Volume (1 Month) | 523.15k |
52 Week Change | 9.99% |
52 Week High | 50.99 |
52 Week Low | 27.985 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.